Logo image
GPIHBP1, an endothelial cell transporter for lipoprotein lipase
Journal article   Open access   Peer reviewed

GPIHBP1, an endothelial cell transporter for lipoprotein lipase

Stephen G Young, Brandon S. J Davies, Constance V Voss, Peter Gin, Michael M Weinstein, Peter Tontonoz, Karen Reue, André Bensadoun, Loren G Fong and Anne P Beigneux
Journal of lipid research, Vol.52(11), pp.1869-1884
11/2011
DOI: 10.1194/jlr.R018689
PMCID: PMC3196223
PMID: 21844202
url
https://doi.org/10.1194/jlr.R018689View
Published (Version of record) Open Access

Abstract

Interest in lipolysis and the metabolism of triglyceride-rich lipoproteins was recently reignited by the discovery of severe hypertriglyceridemia (chylomicronemia) in glycosylphosphatidylinositol-anchored high density lipoprotein–binding protein 1 (GPIHBP1)-deficient mice. GPIHBP1 is expressed exclusively in capillary endothelial cells and binds lipoprotein lipase (LPL) avidly. These findings prompted speculation that GPIHBP1 serves as a binding site for LPL in the capillary lumen, creating “a platform for lipolysis.” More recent studies have identified a second and more intriguing role for GPIHBP1—picking up LPL in the subendothelial spaces and transporting it across endothelial cells to the capillary lumen. Here, we review the studies that revealed that GPIHBP1 is the LPL transporter and discuss which amino acid sequences are required for GPIHBP1–LPL interactions. We also discuss the human genetics of LPL transport, focusing on cases of chylomicronemia caused by GPIHBP1 mutations that abolish GPIHBP1’s ability to bind LPL, and LPL mutations that prevent LPL binding to GPIHBP1.
hypertriglyceridemia Thematic Review endothelial cells lymphocyte antigen 6 proteins chylomicrons chylomicronemia

Details

Metrics

Logo image